Futura Medical's Partnership with Cooper Consumer Health Extended to 2029
#industry #news #UK #2024 #insights #zenopa #recruitment #Futura #Medical #Partnership #Cooper #Consumer #Health
Stay updated with breaking news from Bart Meermans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
#industry #news #UK #2024 #insights #zenopa #recruitment #Futura #Medical #Partnership #Cooper #Consumer #Health
Sexual health pharmaceutical company Futura Medical has extended its exclusive licensing agreement with Cooper Consumer Health for the rights to commercialize its topical, gel-based erectile dysfunction treatment.
Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, today announces it has entered into an exclusive licensing agreement with Cooper Consumer ...
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has granted an exclusive licence for its topical, gel-based erectile dysfunction (ED) treatment MED3000 throughout...
Investegate announcements from Futura Medical PLC, MED3000 Collaboration in EEA, UK & Switzerland